Christopher Gordon Barber

USPTO Granted Patents = 11 (Patent Applications = 1)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 132(Granted Patents)

Location History:

Sandwich, Kent, GB (2000)
Kent, GB (2004)
Sandwich, GB (2001 - 2013)

Company Filing History:

Warner-lambert Company

patents

1 out of 832,680

Other

patents

Years Active: 2000-2013

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8598123 - Peptide analogues (2013-12-03),

2. 8592403 - Diazepine and diazocane compounds as MC4 agonists (2013-11-26),

3. 7141586 - Nicotinamide derivatives useful as PDE4 inhibitors (2006-11-28),

4. 6831074 - Pharmaceutically active compounds (2004-12-14),

5. 6809200 - Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof (2004-10-26),

6. 6784185 - Pharmaceutically active compounds (2004-08-31),

7. 6756373 - Pharmaceutically active compounds (2004-06-29),

8. 6673789 - 2-pyridinylguanidine urokinase inhibitors (2004-01-06),

9. 6583162 - 2-pyridinylguanidine urokinase inhibitors (2003-06-24),

10. 6248738 - Isoquinolines as urokinase inhibitors (2001-06-19),

11. 6093731 - Isoquinolines (2000-07-25),

Title: The Innovative Contributions of Christopher Gordon Barber

Introduction

Christopher Gordon Barber is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 11 patents. His work primarily focuses on the development of compounds that have potential medical applications.

Latest Patents

Among his latest patents are innovative compounds such as peptide analogues, which relate to compounds of Formula (I) and their pharmaceutically acceptable salts. These compounds are particularly noteworthy for their use in medicine, specifically as opioid agonists. Another significant patent involves diazepine and diazocane compounds, which are defined by specific formulas and are useful as MC4 agonists.

Career Highlights

Throughout his career, Barber has worked with prominent organizations, including Pfizer Corporation. His experience in the pharmaceutical industry has allowed him to contribute to the development of groundbreaking medical compounds.

Collaborations

Barber has collaborated with several professionals in his field, including Charlotte Moira Norfor Allerton and Roger P Dickinson. These collaborations have likely enriched his research and development efforts.

Conclusion

Christopher Gordon Barber's innovative work and numerous patents highlight his significant impact on the pharmaceutical industry. His contributions continue to advance medical science and improve therapeutic options.

This text is generated by artificial intelligence and may not be accurate.